Spanish stocks - Factors to watch on Jan 24

Jan 17 (Reuters) - Oryzon Genomics SA: * ANNOUNCES CONVERSION OF CONVERTIBLE BONDS * INVESTOR NICE & GREEN HAS REQUESTED A NEW CONVERSION OF BONDS FOR AN AMOUNT JOINT FACE VALUE OF 1.9 MILLION EUROS,

Jan 11 (Reuters) - Grifols SA: * ACHIEVES POSITIVE TOPLINE RESULTS FROM PHASE 3B STUDY OF ITS FIBRIN SEALANT TO TREAT SURGICAL BLEEDING IN PEDIATRIC PATIENTS * ALL PRIMARY AND SECONDARY ENDPOINTS MET,

Dec 30 (Reuters) - Pharma Mar SA: * INITIATES FIRST HUMAN CLINICAL TRIAL OF A NEW MOLECULE, PM534, FOR CANCER PATIENTS * NEW MOLECULE HAS BEEN TESTED IN THE LABORATORY, BOTH IN CELL CULTURES (IN VITRO

Dec 22 (Reuters) - Pharma Mar SA: * LEADS TERINMUN INITIATIVE, RESEARCH CONSORTIUM IN SEARCH OF IMMUNOTHERAPIES BASED ON MARINE-DERIVED COMPOUNDS * PROJECT APPROVED IN CALL FOR PUBLIC-PRIVATE

Dec 20 (Reuters) - Oryzon Genomics SA: * CONVERSION OF CONVERTIBLE BONDS * INVESTOR HAS PROCEEDED TO CONVERT BONDS FOR A NOMINAL AMOUNT SET OF 1.8 MILLION EUROS, AT A CONVERSION PRICE OF 2.1995 EUROS

Dec 16 (Reuters) - Oryzon Genomics SA: * GETS EU GRANT TO FURTHER EXPLORE ROLE OF IADADEMSTAT IN ONCOLOGICAL IMMUNOTHERAPY APPROACHES * PROJECT WILL START ON MAY 1, 2023 AND WILL RUN FOR TWO YEARS *

MADRID, Dec 14 (Reuters) - Spanish pharmaceutical company Grifols considers selling assets worth about 2 billion euros ($2.12 billion) to cut its debt, Cinco Dias reported on Wednesday, citing

Dec 14 (Reuters) - The following Spanish stocks may be affected by newspaper reports and other factors on Wednesday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy

Dec 13 (Reuters) - Laboratorio Reig Jofre SA: * HAS SUCCESSFULLY COMPLETED CO-DEVELOPMENT OF TRIFERTYATM, FOOD SUPPLEMENT THAT CONTRIBUTES TO MALE FERTILITY Further company coverage: (Gdansk Newsroom)

Dec 13 (Reuters) - The following Spanish stocks may be affected by newspaper reports and other factors on Tuesday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy: